Factors affecting total and "respirable" dose delivered by a salbutamol metered dose inhaler.
β Scribed by Everard, Mark L. (author);Devadason, Sunalene G. (author);Summers, Quentin A. (author);Le Souef, Peter N. (author)
- Book ID
- 121661123
- Publisher
- BMJ Publishing Group
- Year
- 1995
- Tongue
- English
- Weight
- 779 KB
- Volume
- 50
- Category
- Article
- ISSN
- 0040-6376
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Aerosolised DNA administration could potentially advance the treatment of inheritable lung diseases, lung malignancies and provide genetic immunisation against infection. Jet nebulisation, the current standard for introducing DNA formulations into the lung, is inherently inefficient. Pressurised met
In a double-blind cross-over study, 12 patients with reversible airways obstruction were treated with 200 micrograms salbutamol base in aerosol or 400 micrograms of powder following methacholine-induced bronchoconstriction. Salbutamol was inhaled either from a conventional metered dose inhaler (MDI)